ADAR1 Capital Management »

Alector shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Alector (ALEC) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Alector

Tip: Access up to 7 years of quarterly data

All positions including Alector held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alector by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $316k 53k 6.02

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Alector

BlackRock
BlackRock
Vanguard Group
Deep Track Capital
Morgan Stanley
State Street Corporation
Jpmorgan Chase & Co
Soleus Capital Management
Braidwell
Geode Capital Management
Euclidean Capital
Deutsche Bank Aktiengesellschaft
Deerfield Management Company
Jacobs Levy Equity Management
Franklin Resources

View all funds holding Alector